PCIA
CELG

Prime Capital Investment Advisors’s Celgene Corp CELG Stock Holding History

Prime Capital Investment Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-875
Closed -$87K – 680
2019
Q3 		$87K Buy
875
+275
+46% +$26.1K 0.01% 260
2019
Q2 		$55K Hold
600
– – 0.01% 239
2019
Q1 		$57K Buy
600
+476
+384% +$41.6K 0.02% 188
2018
Q4 		$8K Buy
+124
New +$9.15K ﹤0.01% 293
2018
Q3 		– Sell
-66
Closed -$5K – 393
2018
Q2 		$5K Buy
+66
New +$5.48K ﹤0.01% 296

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Prime Capital Investment Advisors's CELG Position: Q4 2019 in Review

Prime Capital Investment Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 875 shares — an estimated $87K sold.

Prime Capital Investment Advisors first reported a position in CELG in Q2 2018 and held it in 5 quarters. The position peaked at $87K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Prime Capital Investment Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Prime Capital Investment Advisors sold 875 Celgene Corp shares in Q4 2019, an estimated $87K.
  • Prime Capital Investment Advisors first reported a position in Celgene Corp in Q2 2018 and held it in 5 quarters.
  • Prime Capital Investment Advisors's Celgene Corp position peaked at $87K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Prime Capital Investment Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.